Literature DB >> 16015372

Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: a meta-analysis.

Keri A Lattimore1, Steven M Donn, Niko Kaciroti, Alex R Kemper, Charles R Neal, Delia M Vazquez.   

Abstract

Selective serotonin reuptake inhibitors (SSRIs) are frequently used to treat depression during pregnancy and the postpartum period. These drugs are capable of crossing the placenta and being transferred to the newborn during lactation. This report reviews the available information regarding the effects of SSRIs on the fetus and newborn; including long-term neurodevelopmental outcomes.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16015372     DOI： 10.1038/sj.jp.7211352

Source DB:  PubMed          Journal:  J Perinatol        ISSN： 0743-8346            Impact factor:   2.521


  32 in total

Review 1.  A 2012 evidence-based algorithm for the pharmacotherapy for obsessive-compulsive disorder.

Authors:  Dan J Stein; Nastassja Koen; Naomi Fineberg; Leonardo F Fontenelle; Hisato Matsunaga; David Osser; H Blair Simpson
Journal:  Curr Psychiatry Rep       Date:  2012-06       Impact factor: 5.285

Review 2.  Investigating outcomes following the use of selective serotonin reuptake inhibitors for treating depression in pregnancy: a focus on methodological issues.

Authors:  Luke E Grzeskowiak; Andrew L Gilbert; Janna L Morrison
Journal:  Drug Saf       Date:  2011-11-01       Impact factor: 5.606

Review 3.  Fetal effects of psychoactive drugs.

Authors:  Amy L Salisbury; Kathryn L Ponder; James F Padbury; Barry M Lester
Journal:  Clin Perinatol       Date:  2009-09       Impact factor: 3.430

4.  Genome-wide DNA methylation in neonates exposed to maternal depression, anxiety, or SSRI medication during pregnancy.

Authors:  Amy L Non; Alexandra M Binder; Laura D Kubzansky; Karin B Michels
Journal:  Epigenetics       Date:  2014-04-21       Impact factor: 4.528

5.  Recent sex trade and injection drug use among pregnant opiate and cocaine dependent women in treatment: The significance of psychiatric comorbidity.

Authors:  Courtenay E Cavanaugh; William W Latimer
Journal:  Addict Disord Their Treat       Date:  2010-03

6.  Identifying Drugs Inducing Prematurity by Mining Claims Data with High-Dimensional Confounder Score Strategies.

Authors:  Romain Demailly; Sylvie Escolano; Françoise Haramburu; Pascale Tubert-Bitter; Ismaïl Ahmed
Journal:  Drug Saf       Date:  2020-06       Impact factor: 5.606

Review 7.  Serotonin reuptake inhibitor-induced perinatal complications.

Authors:  Salvatore Gentile
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

8.  A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight.

Authors:  Hsiang Huang; Shane Coleman; Jeffrey A Bridge; Kimberly Yonkers; Wayne Katon
Journal:  Gen Hosp Psychiatry       Date:  2013-10-02       Impact factor: 3.238

Review 9.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

Review 10.  Could use of Selective Serotonin Reuptake Inhibitors During Lactation Cause Persistent Effects on Maternal Bone?

Authors:  Samantha R Weaver; Laura L Hernandez
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-03-30       Impact factor: 2.673
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.